THC Therapeutics' market value is the price at which a share of THC Therapeutics trades on a public exchange. It measures the collective expectations of THC Therapeutics investors about its performance. THC Therapeutics is selling for under 1.0E-4 as of the 11th of February 2026; that is 99.47 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 1.0E-4. With this module, you can estimate the performance of a buy and hold strategy of THC Therapeutics and determine expected loss or profit from investing in THC Therapeutics over a given investment horizon. Check out THC Therapeutics Correlation, THC Therapeutics Volatility and THC Therapeutics Performance module to complement your research on THC Therapeutics.
Please note, there is a significant difference between THC Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if THC Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, THC Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
THC Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to THC Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of THC Therapeutics.
0.00
11/13/2025
No Change 0.00
0.0
In 3 months and 1 day
02/11/2026
0.00
If you would invest 0.00 in THC Therapeutics on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding THC Therapeutics or generate 0.0% return on investment in THC Therapeutics over 90 days. It is involved in the development of dHydronator, a sanitizing herb dryer for drying and sanitizing of freshly harvested... More
THC Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure THC Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess THC Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for THC Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as THC Therapeutics' standard deviation. In reality, there are many statistical measures that can use THC Therapeutics historical prices to predict the future THC Therapeutics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of THC Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
THC Therapeutics is out of control given 3 months investment horizon. THC Therapeutics retains Efficiency (Sharpe Ratio) of 0.17, which indicates the firm had a 0.17 % return per unit of volatility over the last 3 months. We were able to break down twenty different technical indicators, which can help you to evaluate if expected returns of 22.59% are justified by taking the suggested risk. Use THC Therapeutics risk adjusted performance of 0.1168, and Standard Deviation of 573.6 to evaluate company specific risk that cannot be diversified away. THC Therapeutics holds a performance score of 13 on a scale of zero to a hundred. The entity owns a Beta (Systematic Risk) of 51.49, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, THC Therapeutics will likely underperform. Use THC Therapeutics coefficient of variation, total risk alpha, as well as the relationship between the Total Risk Alpha and rate of daily change , to analyze future returns on THC Therapeutics.
Auto-correlation
-0.18
Insignificant reverse predictability
THC Therapeutics has insignificant reverse predictability. Overlapping area represents the amount of predictability between THC Therapeutics time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of THC Therapeutics price movement. The serial correlation of -0.18 indicates that over 18.0% of current THC Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.18
Spearman Rank Test
0.46
Residual Average
0.0
Price Variance
0.0
Thematic Opportunities
Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
When running THC Therapeutics' price analysis, check to measure THC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy THC Therapeutics is operating at the current time. Most of THC Therapeutics' value examination focuses on studying past and present price action to predict the probability of THC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move THC Therapeutics' price. Additionally, you may evaluate how the addition of THC Therapeutics to your portfolios can decrease your overall portfolio volatility.